Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Apex Resources October 30, 2025 Kerrie Matthews Appointed Managing Director & CEO October 30, 2025 Copper Quest To Acquire 100% Interest in the Kitimat Copper-Gold Project October 30, 2025